Arranged by ESCMID

Convenors: J. Crane (Paris, FR), P.T. Tassios (Athens, GR)

• How to write a review article. S. Gorbach (Boston, US)
• How to design and write up a clinical trial. M. Paul (Petah Tikva, IL)
• How to design and write up a validation study. R. Goering (Omaha, US)
• How to write a research article. P.T. Tassios (Athens, GR)

To view or download this handout, please log in or register.

EW02: Antifungal agents: new topics on resistance, therapeutic drug monitoring and pharmacoeconomy

Arranged with the ESCMID Fungal Infection Study Group (EFISG) and the EUCAST Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST)

Convenors: J.L. Rodriguez Tudela (Madrid, ES), J. Bille (Lausanne, CH)

• Antifungal drug breakpoints: phenotypic, genotypic and clinical resistance. J.L. Rodriguez Tudela (Madrid, ES)
• Therapeutic drug monitoring (TDM) of antifungal agents: how, when, where? R.J. Brüggemann (Nijmegen, NL)
• Pharmacoeconomy and antifungal prescriptions O.A. Cornely (Cologne, DE)

To view or download this handout, please log in or register.

EW03: New insights in frequently observed intestinal parasites

Arranged with the ESCMID Study Group for Clinical Parasitology (ESGCP)

Convenor: T. van Gool (Amsterdam, NL)

• Dientamoeba, an underrecognized intestinal pathogen. Ö. Kurt (Manisa, TR)
• Blastocystis, new insights in a frequently observed intestinal parasite. T. van Gool (Amsterdam, NL)
• Cryptosporidium, Isospora and Cyclospora: clinical importance and outbreak management. F. Derouin (Paris, FR)
• Treatment failure of intestinal protozoal infections. L. Favennec (Rouen, FR)

To view or download this handout, please log in or register.

EW04: Multi-resistant Acinetobacter baumannii – a treatment and infection control dilemmas

Arranged with the ESCMID Study Group for Nosocomial Infections (ESGNI)

Convenors: C. Ruef (Zurich, CH), B.D. Cookson (London, UK)

• Epidemiology of multi-resistant Acinetobacter baumannii in Europe – results of an ESGNI survey. C. Ruef (Zurich, CH)
• Pathogenetic and molecular features. J. Vila (Barcelona, ES)
• Treatment options. M. Falagas (Athens, GR)
• Infection control guidelines. B.D. Cookson (London, UK)

To view or download this handout, please log in or register.

EW05: Diagnosis of bacterial biofilm infections

Arranged with the ESCMID Study Group for Biofilms (ESGB)

Convenor: N. Høiby (Copenhagen, DK)

• Overview of methods for diagnosis of biofilm infections. T. Bjarnsholt (Lyngby, DK)
• Diagnosis of staphylococcal biofilm infections on foreign bodies. H. Rohde (Hamburg, DE)
• Diagnosis of bacterial biofilms in chronic otitis media. G.D. Ehrlich (Pittsburgh, US)
• Diagnosis of bacterial biofilms in chronic sinusitis and pneumonia. N. Hoiby (Copenhagen, DK)

To view or download this handout, please log in or register.

EW06: Practical approaches of Clostridium difficile infections (CDI)

Arranged with the ESCMID Study Group for Clostridium difficile (ESGCD)

Convenor: F. Barbut (Paris, FR)

• How to treat mild and severe CDI? M. Miller (Quebec, CA)
• Routine diagnostics and rapid diagnostics of CDI. F. Barbut (Paris, FR)
• Infection control measurements during a CDI outbreak. J. O'Driscoll (Aylesbury, UK)
• Antibiotic stewardship to prevent the further spread of CDI. S. Stone (London, UK)

To view or download this handout, please log in or register.

EW07: Viruses and the respiratory tract – current and future issues

Arranged with the European Respiratory Society (ERS) for the EU-funded Network of Excellence Genomics to Combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE)

Convenors: R. Finch (Nottingham, UK), L. van der Hoek (Amsterdam, NL)

• Vaccine prevention of non-influenza viral respiratory disease – current and future. A. Osterhaus (Rotterdam, NL)
• Viral interactions with the respiratory tract in health and disease. A. Papi (Ferrara, IT)
• Upper respiratory tract viral infections with impact on the lung. A. Papi and M. Contoli (Ferrara, IT)
• Viral pneumonia – primary and co-pathogenic infections. M. Contoli (Ferrara, IT)
• Current laboratory diagnosis of viral respiratory tract infections. A. Bermingham (London, UK)
• Future diagnostic approaches to viral respiratory tract infections. L. van der Hoek (Amsterdam, NL)
• Identifying novel respiratory viruses – the technology and examples from the GRACE approach. L. van der Hoek (Amsterdam, NL)
• National and international surveillance of viral respiratory infections – strengths, weaknesses and future directions. A. Bermingham (London, UK)

Handout

EW08: Antimicrobial susceptibility testing – practical implementation of the EUCAST breakpoints and methods

Arranged with the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Convenors: G. Kahlmeter (Vaxjo, SE), D. Brown (Peterborough, UK)

• MIC breakpoints – the reference for routine susceptibility testing methods. G. Kahlmeter (Vaxjo, SE)
• Implementation of the EUCAST disk-diffusion method. D. Brown (Peterborough, UK)
• Implementation of EUCAST breakpoints with automated systems. R. Cantón (Madrid, ES)
• Supplementary tests – when routine methods are not enough. F. Tenover (Sunnyvale, US)
• Expert rules in susceptibility testing. R. Leclercq (Caen, FR)
• Gradient tests on EUCAST media. G. Kahlmeter (Vaxjo, SE)

To view or download this handout, please log in or register.

EW09: Optimizing treatment using a pharmacodynamic approach: an interactive workshop using clinical cases

Arranged with the ESCMID PK/PD of Anti-Infectives Study Group (EPASG) and the International Society of Anti-Infective Pharmacology (ISAP)

Convenors: J. Mouton (Nijmegen, NL), U. Theuretzbacher (Vienna, AT)

• Dosing and duration of treatment of aminoglycoside therapy. W. Craig (Madison, US)
• Choosing an antimicrobial for CAP. U. Theuretzbacher (Vienna, AT)
• Continuous infusion of beta-lactams. J. Mouton (Nijmegen, NL)
• Treatment with glycopeptides: intermittent dosing or continuous infusion? H. Derendorf (Gainesville, US)
• Dose adjustments in patients with an impaired renal function. H. Derendorf (Gainesville, US)
• Combination treatment. J. Mouton (Nijmegen, NL)

To view or download this handout, please log in or register.

EW10: The ins and outs of diagnostic tests

Arranged with the Infections Diseases Group (IDF) of the European Organisation for Research and Treatment of Cancer (EORTC)

Convenors: P. Donnelly (Nijmegen, NL), M. Akova (Ankara, TR)

• Measurement of analytical validity – the accuracy and precision, sensitivity and specificity. P. Donnelly (Nijmegen, CH)
• Evaluation of clinical validity, the accuracy with which a test identifies or predicts clinical status – diagnostic odds ratio, PPV/NPV. P. Bossuyt (Amsterdam, NL)
• Assessment of clinical utility – assessment of the risks and benefits, cost and patient outcomes. R. Barnes (Cardiff, UK)

To view or download this handout, please log in or register.

EW11: Development of molecular assays: do's & don't's

Arranged with the ESCMID Study Group for Molecular Diagnostics (ESGMD)

Convenors: M. Raymaekers (Hasselt, BE), P. Savelkoul (Amsterdam, NL)

• QC controls. A.M. van Loon (Utrecht, NL)
• Future developments. K. Templeton (Edinburgh, UK)
• Checklist for optimization and validation of real-time PCR assays. M. Raymaekers (Hasselt, BE)
• Other techniques' validation. U. Reischl (Regensburg, DE)
• Belgian guidelines/Dutch guidelines. M. Raymaekers (Hasselt, BE)
• Expertise and education. P. Savelkoul (Amsterdam, NL)

To view or download this handout, please log in or register.

EW12: Too much on your plate? A practical guide to investigating and controlling outbreaks of food-borne infection in hospitals

Arranged with the ESCMID Food- and Water-borne Infections Study Group (EFWISG)

Convenors: J. Coia (Glasgow, UK), K. Nygard (Oslo, NO)

• Guess what's coming to dinner? Food-borne outbreaks in the hospital setting. K. Kerr (Harrogate, UK)
• Laboratory detection of food-borne infection in hospitals – room for improvement? J. Coia (Glasgow, UK)
• Epidemiological investigation of a suspected outbreak: what do you need to know? K. Nygard (Oslo, NO)
• Managing an outbreak of food-borne infection in hospital – the role of the infection control team. M. Hell (Salzburg, AT)
• The final piece in the puzzle: molecular typing of patient and food-derived isolates. F.X. Weill (Paris, FR)
• It's good to talk – dealing with the media and reassuring the public during an outbreak. B. Adak (Colindale, UK)

To view or download this handout, please log in or register.

EW13: Microbiological methods for screening of MRSA, VRE and ESBL

Arranged with the ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS) and the European Network Mastering Hospital Antimicrobial Resistance in Europe (MOSAR)

Convenors: S. Malhotra-Kumar (Antwerp, BE), E. Cambau (Paris, FR)

• The rationale for screening patients for carriage of antibiotic-resistant bacteria. A. Lee (Geneva, CH)
• Phenotypic and genotypic methods for detection and typing of MDR Gram-positives. E. Cambau (Paris, FR)
• Phenotypic and genotypic methods for detection and typing of MDR Gram-negatives. L. Martinez-Martinez (Santander, ES)
• Statistical methods for comparison of microbiological diagnostic methods. S. Malhotra-Kumar (Antwerp, BE)

To view or download this handout, please log in or register.

EW14: Can we control the development of multiresistant Helicobacter pylori?

Arranged with the European Helicobacter Study Group (EHSG)

Convenors: F. Mégraud (Bordeaux, FR), L.P. Andersen (Copenhagen, DK)

• European multicentre study on H. pylori susceptibility. F. Mégraud (Bordeaux, FR)
• Rationale diagnosis and susceptibility testing. A. Hirschl (Vienna, AT)
• Multiresistant H. pylori: has the test and treat concept run out of time? L.P. Andersen (Copenhagen, DK)
• Current concepts in the treatment of H. pylori infections. Y. Glupczynski (Yvoir, BE)

To view or download this handout, please log in or register.

EW15: Infections by intracellular pathogens: from the laboratory to the clinic

Arranged with the ESCMID Study Group for Coxiella, Anaplasma, Rickettsia and Bartonella (ESCAR)

Convenors: G. Greub (Lausanne, CH), A. Gikas (Heraklion, GR)

• Evolution of serology. A. Gikas (Heraklion, GR)
• Genomics and clinical application. P.E. Fournier (Marseille, FR)
• Culture methods. G. Greub (Lausanne, CH)
• Pharmacokinetics and antibiotic dosage. J.M. Rolain (Marseille, FR)

To view or download this handout, please log in or register.